Bioaffinity technologies reports record q1 revenue driven by accelerating growth of cypath® lung sales and increased laboratory volumes

San antonio--(business wire)-- #biaf--bioaffinity technology reports record q1 2024 revenue driven by accelerating sales of lung cancer diagnostic cypath lung.

BIAF Ratings Summary

BIAF Quant Ranking